Literature DB >> 19287922

Pulmonary arterial hypertension and thyroid disease.

Denise Rossato Silva1, Marcelo Basso Gazzana, Angela Beatriz John, Débora Rodrigues Siqueira, Ana Luiza Silva Maia, Sérgio Saldanha Menna Barreto.   

Abstract

Recent studies have suggested an association between pulmonary arterial hypertension (PAH) and thyroid diseases (hypothyroidism and hyperthyroidism). This combination has a good prognosis, because the increase in the pulmonary artery pressure is usually slight and reverses after the treatment of the thyroid disease. Although the exact mechanism involved in the pathogenesis of this combination has not yet been established, it has been hypothesized that thyroid hormones and autoimmunity have a direct influence. Due to the high prevalence of thyroid disease in patients with PAH, thyroid function tests should be considered in the investigation of every patient with PAH. In this review, we describe the prevalence of PAH in patients with thyroid diseases and the prevalence of thyroid disease in patients with PAH, as well as addressing the principal effects that thyroid diseases have on the respiratory system. In addition, we report the treatment effects in patients with these diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287922     DOI: 10.1590/s1806-37132009000200012

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  11 in total

1.  Pulmonary hypertension and Hashimoto's thyroiditis: does a relationship exist?

Authors:  Marco Matteo Ciccone; Annapaola Zito; Anna Ciampolillo; Michele Gesualdo; Pierluigi Zaza; Marica Rodio; Mariapaola Barbaro; Sergio Di Molfetta; Pietro Scicchitano
Journal:  Endocrine       Date:  2014-07-25       Impact factor: 3.633

Review 2.  The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.

Authors:  Eleni Vrigkou; Evangeline Vassilatou; Effrosyni Dima; David Langleben; Anastasia Kotanidou; Marinella Tzanela
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

3.  Serum thyroid-stimulating hormone levels are not associated with exercise capacity and lung function parameters in two population-based studies.

Authors:  Till Ittermann; Sven Gläser; Ralf Ewert; Stephan Felix; Henry Völzke; Marcus Dörr
Journal:  BMC Pulm Med       Date:  2014-09-02       Impact factor: 3.317

4.  Serum-Free Thyroxine Levels Were Associated with Pulmonary Hypertension and Pulmonary Artery Systolic Pressure in Euthyroid Patients with Coronary Artery Disease.

Authors:  Bingjie Wu; Jingjing Jiang; Minghui Gui; Lin Liu; Qiqige Aleteng; Shanshan Wang; Xiaojing Liu; Yan Ling; Xin Gao
Journal:  Int J Endocrinol       Date:  2017-06-22       Impact factor: 3.257

5.  The burden of comorbidities in pulmonary arterial hypertension.

Authors:  Irene M Lang; Massimiliano Palazzini
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

6.  Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry.

Authors:  Hanna Al-Makhamreh; Abdallah Al-Ani; Dana Alkhulaifat; Liza Shaban; Neveen Salah; Rusul Almarayaty; Yazan Al-Huneidy; Ayman Hammoudeh
Journal:  Ann Med Surg (Lond)       Date:  2022-01-29

7.  Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology.

Authors:  Sibel Ertek; Arrigo F Cicero
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

8.  Assessment of Thyroid Function in Idiopathic Pulmonary Hypertension.

Authors:  Farveh Vakilian; Davod Attaran; Maysam Shegofte; Shahrzad Lari; Sahar Ghare
Journal:  Res Cardiovasc Med       Date:  2016-03-05

9.  Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol.

Authors:  Shaadi Abughazaleh; Zeenat Safdar
Journal:  Case Rep Pulmonol       Date:  2020-01-23

10.  Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.

Authors:  Larisse Vieira Mendes Araruna; Daniela Camargo de Oliveira; Mônica Corso Pereira; Arnaldo Moura Neto; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.